Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. It is a modified antibody and used for the treatment of rheumatoid arthritis in the case of inadequate response to anti-TNFα therapy. Abatacept is used to treat adults with moderate to severe rheumatoid arthritis (RA) as a second line agent, and as a first line agent for people whose RA is severe and rapidly progressing. It also used to treat psoriatic arthritis and juvenile idiopathic arthritis.
The orencia drug market is segmented based on type, application, and geography. On the basis of type, orencia drug market divided into prefilled syringe and vial. Further, the orencia drug market is segmented by application into rheumatoid arthritis, psoriatic arthritis, and other. Geographically, the orencia drug market is sub-divided into North America, Europe, Asia-Pacific, and Rest of the world.
The key market player operating in the orencia drug market includes Bristol-Myers Squibb.
ORENCIA DRUG MARKET SEGMENTS
Market By Type
• Prefilled Syringe
• Vial
Market By Application
• Rheumatoid Arthritis
• Psoriatic Arthritis
• Other
Market By Geography
• North America
• Europe
• Asia-Pacific
• Rest of the world
Key Players
• Bristol-Myers Squibb
Executive Summary
1 Orencia (abatacept) Drug Market Overview
1.1 Product Overview and Scope of Orencia (abatacept) Drug
1.2 Orencia (abatacept) Drug Segment by Type
1.2.1 Global Orencia (abatacept) Drug Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Prefilled Syringe
1.2.3 Vial
1.3 Orencia (abatacept) Drug Segment by Application
1.3.1 Orencia (abatacept) Drug Consumption Comparison by Application (2014-2025)
1.3.2 Rheumatoid Arthritis
1.3.3 Psoriatic Arthritis
1.3.4 Other
1.4 Global Orencia (abatacept) Drug Market by Region
1.4.1 Global Orencia (abatacept) Drug Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Orencia (abatacept) Drug Market Size
1.5.1 Global Orencia (abatacept) Drug Revenue (2014-2025)
1.5.2 Global Orencia (abatacept) Drug Production (2014-2025)
2 Global Orencia (abatacept) Drug Market Competition by Manufacturers
2.1 Global Orencia (abatacept) Drug Production Market Share by Manufacturers (2014-2019)
2.2 Global Orencia (abatacept) Drug Revenue Share by Manufacturers (2014-2019)
2.3 Global Orencia (abatacept) Drug Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Orencia (abatacept) Drug Production Sites, Area Served, Product Types
2.5 Orencia (abatacept) Drug Market Competitive Situation and Trends
2.5.1 Orencia (abatacept) Drug Market Concentration Rate
2.5.2 Orencia (abatacept) Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Orencia (abatacept) Drug Production Market Share by Regions
3.1 Global Orencia (abatacept) Drug Production Market Share by Regions
3.2 Global Orencia (abatacept) Drug Revenue Market Share by Regions (2014-2019)
3.3 Global Orencia (abatacept) Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Orencia (abatacept) Drug Production
3.4.1 North America Orencia (abatacept) Drug Production Growth Rate (2014-2019)
3.4.2 North America Orencia (abatacept) Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Orencia (abatacept) Drug Production
3.5.1 Europe Orencia (abatacept) Drug Production Growth Rate (2014-2019)
3.5.2 Europe Orencia (abatacept) Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Orencia (abatacept) Drug Production (2014-2019)
3.6.1 China Orencia (abatacept) Drug Production Growth Rate (2014-2019)
3.6.2 China Orencia (abatacept) Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Orencia (abatacept) Drug Production (2014-2019)
3.7.1 Japan Orencia (abatacept) Drug Production Growth Rate (2014-2019)
3.7.2 Japan Orencia (abatacept) Drug Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Orencia (abatacept) Drug Consumption by Regions
4.1 Global Orencia (abatacept) Drug Consumption by Regions
4.2 North America Orencia (abatacept) Drug Consumption (2014-2019)
4.3 Europe Orencia (abatacept) Drug Consumption (2014-2019)
4.4 China Orencia (abatacept) Drug Consumption (2014-2019)
4.5 Japan Orencia (abatacept) Drug Consumption (2014-2019)
5 Global Orencia (abatacept) Drug Production, Revenue, Price Trend by Type
5.1 Global Orencia (abatacept) Drug Production Market Share by Type (2014-2019)
5.2 Global Orencia (abatacept) Drug Revenue Market Share by Type (2014-2019)
5.3 Global Orencia (abatacept) Drug Price by Type (2014-2019)
5.4 Global Orencia (abatacept) Drug Production Growth by Type (2014-2019)
6 Global Orencia (abatacept) Drug Market Analysis by Applications
6.1 Global Orencia (abatacept) Drug Consumption Market Share by Application (2014-2019)
6.2 Global Orencia (abatacept) Drug Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Orencia (abatacept) Drug Business
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Orencia (abatacept) Drug Production Sites and Area Served
7.1.2 Orencia (abatacept) Drug Product Introduction, Application and Specification
7.1.3 Bristol-Myers Squibb Orencia (abatacept) Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
8 Orencia (abatacept) Drug Manufacturing Cost Analysis
8.1 Orencia (abatacept) Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Orencia (abatacept) Drug
8.4 Orencia (abatacept) Drug Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Orencia (abatacept) Drug Distributors List
9.3 Orencia (abatacept) Drug Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors
11 Global Orencia (abatacept) Drug Market Forecast
11.1 Global Orencia (abatacept) Drug Production, Revenue Forecast
11.1.1 Global Orencia (abatacept) Drug Production Growth Rate Forecast (2019-2025)
11.1.2 Global Orencia (abatacept) Drug Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Orencia (abatacept) Drug Price and Trend Forecast (2019-2025)
11.2 Global Orencia (abatacept) Drug Production Forecast by Regions (2019-2025)
11.2.1 North America Orencia (abatacept) Drug Production, Revenue Forecast (2019-2025)
11.2.2 Europe Orencia (abatacept) Drug Production, Revenue Forecast (2019-2025)
11.2.3 China Orencia (abatacept) Drug Production, Revenue Forecast (2019-2025)
11.2.4 Japan Orencia (abatacept) Drug Production, Revenue Forecast (2019-2025)
11.3 Global Orencia (abatacept) Drug Consumption Forecast by Regions (2019-2025)
11.3.1 North America Orencia (abatacept) Drug Consumption Forecast (2019-2025)
11.3.2 Europe Orencia (abatacept) Drug Consumption Forecast (2019-2025)
11.3.3 China Orencia (abatacept) Drug Consumption Forecast (2019-2025)
11.3.4 Japan Orencia (abatacept) Drug Consumption Forecast (2019-2025)
11.4 Global Orencia (abatacept) Drug Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Orencia (abatacept) Drug Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
© 2019 Data N Analysis. All Rights Reserved | Design by Data N Analysis